Research Site

Guangzhou, Guangdong 515515

4 studies enrolling now · 12 studies all time

What they study most

ATTR, ATTR-CM, ATTR-Mixed, ATTRv-PN, Acute Coronary Syndrome, Anemia, Cancer, Chronic Kidney Disease, Diabetes, Hyperlipidemia, Mixed Dyslipidemia, Dyslipidemia, Heart Failure, Locally Advanced or Metastatic Solid Tumors Harboring a ROS1 or NTRK Alteration

Studies at this site

• Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis — Recruiting now
• A Study to Investigate ANS02 in Participants With EGFR Mutation-Positive Non-Small Cell Lung Cancer — Recruiting now
• JAB-30355 in Patients With Advanced Solid Tumors Harboring TP53 Y220C Mutation — Recruiting now
• A Study to Investigate ANS03 in Participants With Locally Advanced or Metastatic Solid Tumors — Recruiting now
• REVEAL-CKD: Prevalence and Consequences of Undiagnosed Chronic Kidney Disease — Completed
• Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk — Completed
• Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy — Stopped early
• ASPECCT: A Study of Panitumumab Efficacy and Safety Compared to Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer — Completed
• Registrational Study With Omecamtiv Mecarbil (AMG 423) to Treat Chronic Heart Failure With Reduced Ejection Fraction — Completed
• Safety and Efficacy of Evolocumab in Combination With Statin Therapy in Adults With Diabetes and Hyperlipidemia or Mixed Dyslipidemia — Completed
• Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable CAD in Post MI Patients — Stopped early
• A Comparison of Ticagrelor (AZD6140) and Clopidogrel in Patients With Acute Coronary Syndrome — Completed